Product Reports Resources Pricing Login Book a demo

CURE

Health Tech & Medtech · Berlin, Germany · Founded 2007

Building the "one-stop-shop" platform for healthcare MoreLess

CURE operates within the health technology sector, specifically targeting the digital transformation of local pharmacies. The company provides a B2B solution aimed at integrating brick-and-mortar pharmacies into the digital economy. At the core of its offering is the CURE Order Platform, which functions as an AI-powered Co-Pilot. This platform enables pharmacies to connect with a network of third-party service providers, thereby streamlining their operational workflows.

The business model appears to be centered on facilitating revenue growth for its pharmacy clients. By integrating with various services, the platform allows pharmacies to manage their business operations more efficiently and access new market channels. This suggests a focus on optimizing backend processes, from inventory management to order fulfillment, through a centralized digital hub. The clients are independent and local pharmacies seeking to modernize their services and compete in an increasingly digital marketplace.

The service is designed to bridge the gap between traditional pharmacy operations and modern e-commerce expectations. By using the CURE platform, pharmacies can expand their service offerings and enhance their delivery capabilities. This system aims to improve how pharmacies manage their business, from handling prescriptions to coordinating with delivery services, ultimately enhancing the end-customer experience without the pharmacy needing to build the digital infrastructure from scratch.

Keywords: pharmacy software, health technology, B2B SaaS, pharmaceutical industry, digital transformation, AI co-pilot, order management, pharmacy operations, e-pharmacy, third-party integration

Valuation $0–100M
Revenue $1–10M
Headcount <100
Total funding $10–50M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for CURE and the history behind them.

Company overview

CURE company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2007
Headquarters
Berlin, Germany
Employees
22
Open positions
None listed
Dealroom signal
64.8
client focusb2bsub industryHealth Platformbusiness modelMarketplace & ecommerceindustryHealthsectorHard Tech

Valuation & funding

CURE funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Sep 2022 $17M $66M Abstract Ventures · Breega · J12 Ventures · Pi Labs
SEEDEquity / VC Feb 2022 $4.4M $18M Abstract Ventures · J-Ventures · Craft Ventures · J12 Ventures
Showing 2 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $4.8M 0% 22
2025 $4.8M 0% 23
2024 $4.8M 0% 25
2023 $4.8M +37.1% 37
2022 $3.5M 38
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

CURE website traffic

Latest recorded traffic for CURE is 1.8K monthly website visits, up 119.5% over the last three months. CURE's team declined 4.3% over the past year.

Latest monthly visits1.8K 3-month web change+119.5% 1-year team growth-4.3%
Monthly website visits45 observations · Nov 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

CURE compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

CURE's talent

Book a demo to see the people
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on CURE's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Abstract Ventures
J-Ventures
Craft Ventures
J12 Ventures
Series A 2 investors entered at this stage
Breega
Pi Labs
Other known 1 additional known investor
Adam Jafer

Global footprint

Where CURE has talent and traffic

Workforce by country
4 countries with
team presence
🇮🇳 India42.9%
🇩🇪 Germany28.6%
🇸🇪 Sweden14.3%
🇹🇳 Tunisia7.1%
4 countries shown

In the news

Latest news about CURE

Recent press, funding announcements, and product moves mentioning CURE — open to read from the original sources.

See all news

Market sentiment

What the market is saying about CURE

An AI-synthesized read of the highest-engagement posts about CURE on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CURE’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.